Autologous Transplantation for Multiple Myeloma in the Era of New Drugs: A Phase III Study of the Intergroupe Francophone Du Myelome (IFM/DFCI 2009 Trial)

被引：1

作者：

Attal, Michel ^{[1
]}

Lauwers-Cances, Valerie ^{[2
]}

Hulin, Cyrille ^{[3
]}

Facon, Thierry ^{[4
]}

Caillot, Denis ^{[5
]}

Escoffre, Martine ^{[6
]}

Arnulf, Bertrand ^{[7
]}

Macro, Margaret ^{[8
]}

Belhadj, Karim ^{[9
]}

Garderet, Laurent ^{[10
]}

Roussel, Murielle ^{[11
,12
]}

Mathiot, Claire ^{[13
]}

Avet-Loiseau, Herve ^{[1
]}

Munshi, Nikhil C. ^{[14
,15
]}

Richardson, Paul G. ^{[16
]}

Anderson, Kenneth C. ^{[17
]}

Harousseau, Jean Luc ^{[18
]}

Moreau, Philippe ^{[19
]}

机构：

[1] Inst Univ Canc Toulouse Oncopole, Toulouse, France

[2] CHU Toulouse, Toulouse, France

[3] CHRU Hop Brabois, Nancy, France

[4] CHRU Lille, Hop Claude Huriez, Malad Sang, F-59037 Lille, France

[5] Hop Bocage, Dijon, France

[6] CHU Rennes, Rennes, France

[7] Hop St Louis, Paris, France

[8] CHU Caen, F-14000 Caen, France

[9] CHU Henri Mondor, F-94010 Creteil, France

[10] Hop St Antoine, F-75571 Paris, France

[11] Inst Univ Canc, Toulouse, France

[12] Univ Hosp, Dept Hematol, Toulouse, France

[13] IFM, Paris, France

[14] Harvard Univ, Sch Med, Dana Farber Canc Inst, LeBow Inst Myeloma Therapeut, Boston, MA 02115 USA

[15] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA

[16] Harvard Univ, Sch Med, Dana Farber Canc Inst,Div Hematol Malignancy, Jerome Lipper Multiple Myeloma Ctr,Dept Med Oncol, Boston, MA 02115 USA

[17] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA

[18] HAS, Paris, France

[19] Nantes Univ Hosp, Dept Hematol, Nantes, France

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[21] Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myelome
Yakoub-Agha, Ibrahim
Mary, Jean-Yves
Hulin, Cyrille
Doyen, Chantal
Marit, Gerald
Benboubker, Lotfi
Voillat, Laurent
Moreau, Philippe
Berthou, Christian
Stoppa, Anne-Marie
Maloisel, Frederic
Rodon, Philippe
Dib, Mamoun
Pegourie, Brigitte
Casassus, Philippe
Slama, Borhane
Damaj, Ghandi
Zerbib, Robert
Harousseau, Jean-Luc
Mohty, Mohamad
Facon, Thierry
EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 88 (03) : 249 - 259
[22] Ixazomib and daratumumab without dexamethasone (I-Dara) in elderly frail RRMM patients: A multicenter phase 2 study (IFM 2018-02) of the Intergroupe Francophone du Myelome (IFM).
Leleu, Xavier
Macro, Margaret
Touzeau, Cyrille
Mariette, Clara
Manier, Salomon
Brechignac, Sabine
Vincent, Laure
Hebraud, Benjamin
Decaux, Olivier
Schulmann, Samantha
Lenoir, Caroline
Godmer, Pascal
Farge, Agathe
Saint Paul, Laure Peyro
Parienti, Jean-Jacques
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[23] Front-Line Transplantation Program With Lenalidomide, Bortezomib, and Dexamethasone Combination As Induction and Consolidation Followed by Lenalidomide Maintenance in Patients With Multiple Myeloma: A Phase II Study by the Intergroupe Francophone du Myelome
Roussel, Murielle
Lauwers-Cances, Valerie
Robillard, Nelly
Hulin, Cyrille
Leleu, Xavier
Benboubker, Lotfi
Marit, Gerald
Moreau, Philippe
Pegourie, Brigitte
Caillot, Denis
Fruchart, Christophe
Stoppa, Anne-Marie
Gentil, Catherine
Wuilleme, Soraya
Huynh, Anne
Hebraud, Benjamin
Corre, Jill
Chretien, Marie-Lorraine
Facon, Thierry
Avet-Loiseau, Herve
Attal, Michel
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) : 2712 - +
[24] Ixazomib and daratumumab without dexamethasone (I-Dara) in elderly frail patients with RRMM: Results of the multicenter phase 2 study (IFM 2018-02) of the Intergroupe Francophone du Myelome (IFM)
Touzeau, Cyrille
Leleu, Xavier P.
Mariette, Clara
Manier, Salomon
Brechignac, Sabine
Vincent, Laure
Hebraud, Benjamin
Decaux, Olivier
Schulmann, Samantha
Lenoir, Caroline
Godmer, Pascal
Farge, Agathe
Saint Paul, Laure Peyro
Parienti, Jean-Jacques
Macro, Margaret
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[25] SEVERE INFECTION IN ELDERLY PATIENTS TREATED WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: ANALYSIS OF THE INTER-GROUPE FRANCOPHONE DU MYELOME (IFM) 2009 01 PROTOCOL
Rodon, P.
Pegourie, B.
Garderet, L.
Casassus, P.
Decaux, O.
Roussel, M.
Chaleteix, C.
Royer, B.
Tiab, M.
Leleu, X.
Mathiot, C.
Hulin, C.
Moreau, P.
Lortholary, O.
Fermand, J. -P.
HAEMATOLOGICA, 2015, 100 : 501 - 502
[26] Ixazomib and Daratumumab without Dexamethasone (I-Dara) in Elderly Frail RRMM Patients. a Multicenter Phase 2 Study (IFM 2018-02) of the Intergroupe Francophone Du Myelome (IFM)
Macro, Magaret
Touzeau, Cyrille
Mariette, Clara
Manier, Salomon
Brechignac, Sabine
Vincent, Laure
Hebraud, Benjamin
Decaux, Olivier
Schulmann, Samantha
Lenoir, Caroline Bureau
Godmer, Pascal
Parienti, Jean-Jacques
Leleu, Xavier
BLOOD, 2021, 138
[27] Thalidomide salvage therapy following allogeneic stem cell transplantation for multiple myeloma: a retrospective study from the Intergroupe Francophone du Myelome (IFM) and the Societe Francaise de Greffe de Moelle et Therapie Cellulaire (SFGM-TC)
Mohty, M
Attal, M
Marit, G
Bulabois, CE
Garban, F
Gratecos, N
Rio, B
Vernant, JP
Sotto, JJ
Cahn, JY
Blaise, D
Jouet, JP
Facon, T
Yakoub-Agha, I
BONE MARROW TRANSPLANTATION, 2005, 35 (02) : 165 - 169
[28] Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myelome 2009-02
Leleu, Xavier
Attal, Michel
Arnulf, Bertrand
Moreau, Philippe
Traulle, Catherine
Marit, Gerald
Mathiot, Claire
Petillon, Marie Odile
Macro, Margaret
Roussel, Murielle
Pegourie, Brigitte
Kolb, Brigitte
Stoppa, Anne Marie
Hennache, Bernadette
Brechignac, Sabine
Meuleman, Nathalie
Thielemans, Beatrice
Garderet, Laurent
Royer, Bruno
Hulin, Cyrille
Benboubker, Lotfi
Decaux, Olivier
Escoffre-Barbe, Martine
Michallet, Mauricette
Caillot, Denis
Fermand, Jean Paul
Avet-Loiseau, Herve
Facon, Thierry
BLOOD, 2013, 121 (11) : 1968 - 1975
[29] Daratumumab Plus Ixazomib, Lenalidomide, and Dexamethasone As Extended Induction and Consolidation Followed By Lenalidomide Maintenance in Standard-Risk Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (IFM 2018-01): A Phase II Study of the Intergroupe Francophone Du Myelome (IFM)
Perrot, Aurore
Lauwers-Cances, Valerie
Touzeau, Cyrille
Decaux, Olivier
Hulin, Cyrille
Macro, Magaret
Stoppa, Anne-Marie
Chretien, Marie Lorraine
Karlin, Lionel
Mariette, Clara
Jacquet, Caroline
Roussel, Murielle
Guillemot, Coralie
Devlamynck, Laure
Avet-Loiseau, Herve
Moreau, Philippe
Attal, Michel
BLOOD, 2021, 138
[30] The impact of multiple myeloma drugs treatments on autologous stem cell transplantation in the era of new drugs
Wan, Xixi
Yu, Tian
Yu, Tao
Cai, Huili
FRONTIERS IN ONCOLOGY, 2025, 15

← 1 2 3 4 5 →